Field trial of inactivated oral cholera vaccines in Bangladesh: results from 5 years of follow-up

By van Loon F.P.L.   Clemens J.D.   Chakraborty J.   Rao M.R.   Kay B.A.   Sack D.A.   Yunus M.   Ali M.   Svennerholm A.-M.   Holmgren J.  

Vaccine, Vol. 14, Iss. 2, 1996-02 ,pp. : 162-166

Elsevier

Access to resources Recommend Favorite

Good immunogenicity of GBM strain inactivated hepatitis A vaccine in healthy male adults

By Garin D.   Vidor E.   Wallon M.   Fanget B.   Brasseur P.   Delolme H.   Caron F.   Mojon M.   Gravey A.   Humbert G.   Flehmig B.   Peyron F.  

Vaccine, Vol. 13, Iss. 2, 1995-02 ,pp. : 220-224

Elsevier

Access to resources Recommend Favorite

Low-dose intradermal administration of recombinant hepatitis B vaccine in children: 5-year follow-up study

By Kurugol Z.   Erensoy S.   Aksit S.   Egemen A.   Bilgic A.  

Vaccine, Vol. 19, Iss. 28, 2001-07 ,pp. : 3936-3939

Elsevier

Access to resources Recommend Favorite

Safety and immunogenicity of a new formulation of an inactivated hepatitis A vaccine

By Dagan R.   Greenberg D.   Goldenbertg-Gehtman P.   Vidor E.   Briantais P.   Pinsk V.   Athias O.   Dumas R.  

Vaccine, Vol. 17, Iss. 15, 1999-04 ,pp. : 1919-1925

Elsevier

Access to resources Recommend Favorite

Safety and immunogenicity of a trivalent, inactivated, mammalian cell culture-derived influenza vaccine in healthy adults, seniors, and children

By Halperin S.A.   Smith B.   Mabrouk T.   Germain M.   Trepanier P.   Hassell T.   Treanor J.   Gauthier R.   Mills E.L.  

Vaccine, Vol. 20, Iss. 7, 2002-01 ,pp. : 1240-1247

Elsevier

Access to resources Recommend Favorite